Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Priority Review Costs Remain Stable While Voucher Fee Ticks Up
01 Sep 2014
•
By
Derrick Gingery
Formula was changed to better calculate the cost of a priority review, FDA says.
More from Archive
More from Pink Sheet